Back to Results
First PageMeta Content
Bacteria / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Pyrazinamide / Latent tuberculosis / Rifampicin / Extensively drug-resistant tuberculosis / Isoniazid / Moxifloxacin / Tuberculosis / Medicine / Chemistry


Series Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang
Add to Reading List

Document Date: 2010-05-19 10:24:07

Open Document

File Size: 296,72 KB

Share Result on Facebook

City

Stellenbosch / Tianjin / Oxford / Geneva / New York / Ladenheim / Rifampicin / London / Efavirenz / /

Company

Gonzalez LC / MDR / ADP / Nikonenko BV / LG / Cox / Medline / /

Country

Switzerland / South Africa / United Kingdom / China / United States / /

Currency

pence / /

/

Event

FDA Phase / Product Issues / /

Facility

University of Stellenbosch / University of Cape Town / Cochrane Library / Chaisson R. Building / University College London Medical School / Weir SJ / /

IndustryTerm

Search terms / health systems / AIDS treatment / biotechnology / treatment of XDR disease / chemical compounds / treatment for active disease / Online May / literature search / /

MedicalCondition

rifapentine cures tuberculosis / MDR tuberculosis / JE / HIV / paediatric tuberculosis / microbial infections / such infections / drug-susceptible tuberculosis / Mycobacterium tuberculosis infection / M tuberculosis / chemotherapeutic strategy Latent tuberculosis infection / drug-resistant tuberculosis / multidrug-resistant tuberculosis / drug-susceptible and drug-resistant tuberculosis / childhood tuberculosis / active tuberculosis / active disease / latent infection / drug-susceptible pulmonary tuberculosis / AIDS / HIV/AIDS / infection / extensively drug-resistant tuberculosis / infectious tuberculosis / mycobacterial infections / advanced disease / aerosol infection / TB / murine tuberculosis / tuberculosis epidemic / XDR tuberculosis / tuberculosis infection / established infection / Global tuberculosis / XDR disease / childhood intra-thoracic tuberculosis / experimental tuberculosis / HIV-related tuberculosis / treatment MDR tuberculosis / HIV infection / latent tuberculosis infection / et al. The HIV-associated tuberculosis epidemic / opportunistic infections / disease / pulmonary tuberculosis / Mycobacterium tuberculosis / M tuberculosis infection / disseminated disease / XDR / latent tuberculosis / Series Tuberculosis / latent disease / drug sensitive tuberculosis / tuberculosis / /

MedicalTreatment

immunosuppression / chemoprophylaxis / chemo / antiretroviral therapy / antibiotics / chemotherapy / Drug therapy / /

Organization

Stop TB Department / World Health Organization / Joint Tuberculosis Committee / Clinical Trials Unit / Department of Medicine / British Medical Research Council / University of Cape Town / Cape Town / University of Stellenbosch / British Thoracic Society / University College London Medical School / TB Alliance / Several / Global Alliance for TB Drug Development / Tuberculosis Committee on Prophylaxis / Division of Clinical Pharmacology / Stop TB Partnership Secretariat / /

Person

Mario Raviglione / Helen McIlleron / Joanna Breitstein / Comb Chem / Chase S. Activities / Van Cutsem / Christian Lienhardt / Ben J Marais / Van Devanter / Zhenkun Ma / Van Niekerk / /

Position

Walker / /

Product

kanamycin / efavirenz / ofloxacin / linezolid / pyrazinamide / nevirapine / cipro / Oxazolidinone / isoniazid / rifampin / levofloxacin / gatifloxacin / nitro / SJ / PNU-100480 / AZD-5847 / TMC-207 / global capacity / CYP3A4 / SQ-109 / P450 / OPC-67683 / /

ProvinceOrState

New York / /

RadioStation

80 Ginsberg AM / 54 Ginsberg AM / 53 Ginsberg AM / Ginsburg AM / /

Technology

diagnostic tests / high-throughput screening / drug discovery / chemotherapy / biotechnology / Pharmacokinetics / drug development / /

URL

http /

SocialTag